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Summary 
Cells respond to diverse external stimuli by polymeriz- 
ing cytoplasmic actin, and recent evidence indicates 
that GTPases can specify where this polymerization 
takes place. Actin assembly in stimulated blood plate- 
lets occurs where sequestered monomers add onto the 
fast-growing (barbed) ends of actin filaments (F-actin), 
which are capped in the resting cells. We report that 
D3 and D4 polyphosphoinositides, Pl(4)P, Pl(4,5)P2, 
Pl(3,4)P2, and Pl(3,4,5)P3, uncap F-actin in resting per- 
meabilized platelets. The thrombin receptor-activat- 
ing peptide (TRAP), GTP, and GTPyS, but not GDPPS, 
also uncap F-actin in permeabilized platelets. GDPf3S 
inhibits TRAP-induced F-actin uncapping, and Pl(4,5)P2 
overcomes this inhibition. Constitutively active mu- 
tant Rat, but not Rho, activates uncapping of F-actin. 
Pl(4,5)P2-binding peptides derived from gelsolin in- 
hibit F-actin uncapping by TRAP, Rat, and GTPyS. 
TRAP and Rat induce rapid Pl(4,5)P2 synthesis in per- 
meabilized platelets. Thefindingsestablish asignaling 
pathway for actin assembly involving Rat in which the 
final message is phosphoinositide-mediated F-actin 
uncapping. 
Introduction 
Human platelets are tiny oval discs, 7 fl in volume, that 
circulate in the blood at a concentration of 2.5 x lOa/ 
ml. They are subject to stimulation by numerous agents 
generated by tissue injury, following which they undergo 
a profound shape transformation. First, the disc expands 
into a sphere, and then it projects two types of surface 
protrusions, flat lamellae and finger-like filopodia. The la- 
mellae adhere to injured surfaces to plug vascular leaks, 
and the filopodia bind fibrin strands and other platelets to 
form a three-dimensional blood clot. These reactions are 
responsible for physiological hemostasis and also for 
thromboses associated with pathological states such as 
myocardial infarctions, peripheral vascular insufficiency, 
and strokes. 
Remodeling of the actin filament scaffolding that holds 
the resting platelet in the discoid configuration is responsi- 
ble for the cellular shape change, and the biochemistry 
and morphology of the actin remodeling have been the 
subject of much investigation (Fox, 1993; Fox et al., 1984; 
Hartwig, 1992; Nachmiaset al., 1993). The polymeric actin 
cytoskeleton of the resting platelet consists of 2000 actin 
filaments cross-linked by the actin gelation factor ABP-280 
(platelet filamin) and utilizes 40% of the 0.5 mM actin con- 
tained within the cell. The remainder of the actin is largely 
in the form of individual monomeric subunits, bound as 
1 :l complexes to a small polypeptide (thymosin 64) or to 
profilin. As presently conceptualized, thymosin 84 inhibits 
the spontaneous nucleation of monomeric actin that is 
required for polymerization (Safer et al., 1990). Based on 
biochemical data, however, the fast-growing ends of actin 
filaments (conventionally designated as barbed in refer- 
ence to arrowheads conferred by bound myosin head do- 
mains) have a higher affinity for actin monomers than thy- 
mosin 84, and profilin-actin complexes can add directly 
to the barbed end but not to the pointed end of filaments. 
Therefore, thymosin (34 can keep 60% of the total platelet 
actin unpolymerized only if the actin filament barbed ends 
in the cytoskeleton of the resting platelet are blocked 
(“capped”) (Nachmias et al., 1993; Pantaloni and Carlier, 
1993). The barbed ends of actin filaments in detergent- 
permeabilized resting platelets do not accommodate addi- 
tion of actin subunits, consistent with these ends being 
capped, but barbed ends of actin filaments do become 
available to nucleate actin assembly following exposure 
of the cells to stimuli that elicit the platelet shape change 
(Hartwig, 1992; Nachmias et al., 1993). 
One interesting question concerns the signal transduc- 
tion mechanisms that regulate the actin remodeling in the 
activating platelet. Strong evidence indicates that calcium 
is required for the disc-to-sphere transformation that pre- 
cedes actin polymerization and for the protrusion of flat 
lamellae, because the nature of the shape change and 
the extent of exposure of cryptic barbed ends depend on 
the ability of the platelet to increase its intracellular calcium 
concentration. Following platelet stimulation, the intracel- 
lular calcium rises from the basal nanomolar to micromolar 
levels (Davies et al., 1989). The source of calcium in this 
reaction is both extracellular and intracellular. Release of 
calcium from intracellular stores depends on the hydroly- 
sisof phosphatidylinositol(4,5)bisphosphate (P1(4,5)P2) by 
phospholipase Cf3 to generate inositol trisphosphate, a 
reaction dependent upon a pertussis toxin-sensitive het- 
erotrimeric GTPase (Brass et al., 1986). In this setting, the 
usual disc-to-sphere transformation takes place, several 
hundred barbed actin filament ends uncap, and the plate- 
let extrudes lamellae and filopodia. An intermediate step 
in this reaction is a marked shortening of the actin fila- 
ments in the resting platelets, best explained by a calcium- 
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dependent actin filament-severing reaction mediated by 
calcium-activated actin filament-rupturing proteins, such 
as gelsolin, that reside within platelets (Hartwig, 1992). In 
support of this mechanism, platelets genetically devoid of 
gelsolin do not demonstrate the actin filament-shortening 
phenomenon (Witke et al., 1995). A permeant calcium- 
chelating agent that prevents the normal calcium transient 
and should therefore inhibit calcium-dependent actin fila- 
ment-severing proteins has the same effect (Hartwig, 
1992). Platelets lacking gelsolin or unable to raise intracel- 
lular calcium when activated extend filopodia but not la- 
mellae. 
Although calcium affects actin filament assembly, it 
does not mediate uncapping per se. In fact, micromolar 
calcium is required for actin filament barbed end capping 
by proteins of the gelsolin family in vitro, and although 
removal of calcium reverses capping by some members 
of this class of proteins, such as CapG and villin, it does not 
have this effect on others, including gelsolin or its homolog 
severin, or on an ubiquitous structurally unrelated barbed 
end capping protein of muscle and nonmuscle cells (Heiss 
and Cooper, 1991). Therefore, although platelets lacking 
gelsolin or prevented from increasing cytoplasmic free cal- 
cium following stimulation fail to sever their actin filaments, 
they do uncap them, and the uncapped barbed ends elon- 
gate extensively. Consistent with their inability to make 
additional barbed ends by severing, however, the number 
of uncapped barbed ends in these platelets is markedly 
diminished compared with gelsolin-containing or unche- 
lated platelets (Hat-twig, 1992; Witke et al., 1995). 
The only physiological agents identified that remove 
barbed end capping proteins from the filament ends in 
vitro are the D4 polyphosphoinositides, phosphatidylinosi- 
tol4-phosphate (Pl(4)P) and Pl(4,5)P2 (Janmey, 1994; Jan- 
mey and Stossel, 1989; Heiss and Cooper, 1991). Evi- 
dence that these phospholipids mediate barbed end 
uncapping in platelets or other cells, however, has thus 
far only been correlative. Thrombin stimulation of platelets 
initially diminishes by about 30% the high (200 PM) con- 
centration of Pl(4,5)P2 found in resting cells. Within 15- 
30 s, however, Pl(4,5)P2 concentration rises to 40% over 
the resting baseline (Agranoff et al., 1983; Grondin et al., 
1991). This overshoot provides the cell with an additional 
-50 PM Pl(4,5)Pa. The fall in phosphoinositides parallels 
the time course of the calcium rise and a transient appear- 
ance of gelsolin-actin complexes in extracts of stimulated 
platelets (Lind et al., 1987). The gelsolin-actin complexes 
then dissociate as the phosphoinositide level recovers in 
conjunction with a net increase in polymerized actin. Some 
(Apgar, 1995; Carson et al., 1992; Chaponnier et al., 1987) 
but not all (Dadabay et al., 1991) studies with other cell 
types documented similar temporal correlations between 
D4 phosphoinositide metabolism and actin assembly. Bio- 
synthesis of D3 phosphoinositides also accompanies 
platelet activation (Gaudette et al., 1993; Grondin et al., 
1991; Kucera and Rittenhouse, 1990; Sultan et al., 1991; 
Zhang et al., 1992,1993), although inhibition of phosphati- 
dylinositol 3-kinase activity has no detectable effect on 
barbed end exposure or net actin assembly in thrombin- 
stimulated platelets (Kovacsovics et al., 1995). If phospho- 
inositides uncap actin filaments in activated platelets, then 
the D4 class of these phospholipids is sufficient for most 
of this activity. Therefore, we have focused on the role of 
the D4 phosphoinositides in barbed end uncapping in 
these cells. 
To obtain direct evidence for phosphoinositide-medi- 
ated barbed end uncapping in platelets and to begin to 
trace the signal transduction pathways linking surface 
stimulation to this uncapping event, we have taken advan- 
tage of two recent methodological advances. One is the 
development of a permeabilization scheme (described in 
this paper) that prepares platelets capable of uncapping 
barbed ends in response to stimulation of the thrombin 
receptor, of synthesizing phosphoinositides, and into 
which signal transduction intermediates and inhibitors can 
be delivered. The second is the availability of specific high 
affinity phosphoinositide-binding peptides derived from 
gelsolin (Janmey et al., 1992) that can be used to probe 
the role of phosphoinositides in the signal transduction 
mechanism. 
Results 
Relationship among Exposure of Barbed Actln 
Filament Ends, Actin Assembly, and Mass Content 
of D4 Phosphoinositides Following Thrombin 
Receptor Perturbation in Intact Platelets 
Resting platelets have - 70 exposed barbed ends per cell, 
representing less than 4% of all the barbed ends present 
in a resting platelet (Hartwig, 1992). After activation of 
platelets by 10 pM thrombin receptor-activating peptide 
(TRAP), the number of exposed barbed filament ends rap- 
idly increases (Figure 1). Approximately 280 free barbed 
ends appear 15 s after TRAP activation, increasing to a 
maximal value of -580 after 80 s. Therefore, after maxi- 
mal activation, 20%-25% of the total barbed filament ends 
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Figure 1. Temporal Relationship among D4 Polyphosphoinositide 
Changes, Exposure of Barbed Filament Ends, and Actin Assembly in 
Platelets Activated with 10 VM TRAP 
Samples were simultaneously assayed for barbed filament ends (open 
circles), F-actin content (closed circles, inset), and the D4 polyphos- 
phoinositides, Pl(4)P (diamonds) and Pl(4,5)P2 (squares), 
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Figure 2. TRAP Uncaps Actin Filaments in 
Platelets Permeabilized with OG 
(A) The ability of platelet lysates to stimulate 
the rate of pyrene-actin assembly in vitro was 
determined. Resting ceils (closed circles) or 
cells activated with 10 uM TRAP for 1 min (open 
circles) were extracted with 0.4% CG. Resting 
cells permeabilized for 2 min were activated 
using 10 uM TRAP for 1 min prior to addition 
of pyrene-actin (open squares). Actin assem- 
bly in TRAP-activated cells was predominantly 
from the barbed ends of ftlaments as defined 
by cytcchafasin B inhibition (closed squares). 
The rate of actin assembly in the presence and 
absence of cell lysates was determined, and 
the number of exposed barbed ends was calcu- 
lated. They are 360 f 42 for TRAP-activated 
and then permeabilized cells, 315 f 32 for 
permeabilized and then TRAP-treated cells, 
and 90 f 25 for resting cells (mean f SD, 
n = 3). 
(8) Comparison of the TRAP dose responses in 
intact and permeabilized cells. Platelets were 
stimulated with TRAP for 1 min prior to perme 
abilization (open circtes) or permeabilized us- 
ing 0.4% OG for 2 min and then treated with 
TRAP (squares). 
(C) Relationship of the amount of detergent 
used to permeabilize the cells and the retention 
of TFtAF-mediated filament end exposure. 
Platelets permeabilized in increasing concen- 
trations of OG for 2 min were exposed to 25 pM TRAF for 1 min. and barbed end exposure was determuted. 
(D) Relationship between the concentration of OG required to permeabilize platelets and detect filament ends. Cells were activated with 25 uhf 
TRAP for 1 min and then permeabilized with 1110 vol of 10x detergent in PHEM buffer. Data are compared with cells permeabilized in Triton 
X-100 previously shown to yield maximal detection of filament ends. Each point is the mean f SD (n = 3). 
are now available to promote actin assembly. Increased 
assembly of actin into filaments was detectable within 15 
s after the addition of TRAP. At this timepoint, the number 
of exposed barbed filament ends increased 3-fold over the 
resting value. Maximal filament assembly occurred 75 s 
after TRAP treatment, - 30 s following the highest extent 
of barbed filament end exposure. TRAP caused rapid 
changes in phosphoinositide metabolism, resembling pre- 
viously reported alterations in thrombin-stimulated plate- 
lets; Pl(4,5)P2 and Pl(4)P decreased transiently but rapidly 
rose above baseline in conjunction with filament un- 
capping and net actin assembly. 
OG-Permeabilized Platelets Also Expose Barbed 
Filament Ends When Activated by TRAP 
Permeabilization of resting platelets with the detergent 
n-octyl-P-glucopyranoside (OG) maintains the signal trans- 
duction system from the thrombin receptor to actin fila- 
ment ends. Cells permeabilized with 0.4% OG and then 
treated with TRAP for 1 min increased the number of free 
barbed filament ends 3.5fold (Figure 2A), corresponding 
to an increase in the number of free barbed ends from 
the resting level of 90 to 315, - 60% of the sum achieved 
after TRAP activation of intact cells. Exposure of filament 
ends was restricted to the barbed ends in the OG- 
permeabilized cells, since 2 PM cytochalasin 6, an agent 
that predominately binds to the barbed end and inhibits 
monomer assembly onto this end, abolished all detectable 
TRAP-stimulated actin assembly. TRAP had no effect on 
filament ends of platelets permeabilized with Triton X-100 
(data not shown). 
The retention of TRAP sensitivity in OG-treated platelets 
was dependent on the detergent concentration. For reten- 
tion of detectable filament end exposure after ligation of 
the thrombin receptor with TRAP, 0.4% OG was narrowly 
optimal. Platelets treated with higher or lower OG concen- 
trations were unresponsive to TRAP (Figures 2C and 3). 
Filament ends in TRAP-activated cells become detectable 
between 0.375%-0.5% concentrations of OG, and the 
maximal sensitivity to TRAP was limited to 0.4%-0.450/b 
OG. These findings imply that TRAP-mediated actin fila- 
ment uncapping requires both permeable cells and cells 
that retain sufficient membrane. Observations on the ef- 
fect of this detergent on the platelet plasma membrane in 
the electron microscope supported this idea (Figure 3). 
Small holes, 20-100 nm in diameter, first appear after 
0.4% OG treatment (Figure 36). Increasing the OG con- 
centration further to 0.45% or 0.5% results in extensive 
disruption of the membrane surface (Figures 3C and 3D). 
In both intact and permeabilized cells, doses of TRAP 
as low as 1.25 uM initiate filament end uncapping, while 
23.3 uM TRAP maximally exposes barbed filament ends 
(Figure 2B). TRAP at 3.3 PM has been shown by other 
investigators to activate platelets optimally as measured 
by calcium mobilization, secretion, and aggregation (Ras- 
mussen et al., 1993). 
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Figure 3. Effect of OG on the Integrity of the 
Resting Platelet Plasma Membrane 
The percent of OG used to treat each platelet 
sample is indicated in the upper left corner of 
each micrograph. OG at 0.35% did not perme- 
abilize the plasma membrane. The white 
arrows show openings of the open canalicular 
system of the resting platelet. OG at 0.4% pro- 
duced small holes in the plasma membrane, 
varying in size ranging from 20 nm to 200 nm 
in diameter and clustered at various points on 
the surface, but left large regions of the mem- 
brane intact. OG at 0.45% eroded large regions 
of the plasma membrane, exposing the under- 
lying membrane skeleton. Higher (30.5%) con- 
centrations of OG removed most of the mem- 
brane and the underlying membrane skeleton. 
The scale bar represents 200 nm. 
Role of Poiyphosphoinositides in Barbed Filament 
End Exposure 
The addition of Pl(4,5)PZ, phosphatidylinositoi (3,4)bisphos- 
phate (Pi(3,4)P& or Pi(4)P miceiles to OG-permeabiiized 
platelets increases the number of free barbed filament 
ends (Figure 4A). Addition of as little as 20 uM Pi(4,5)P2 
increased the number of exposed barbed filament ends 
P-fold. Maximal barbed end exposure required -50 uM 
Pi(4,5)Pn and increased the barbed end number 3.0- to 
3.5-fold relative to the permeabilized resting ceils. Treat- 
ment of permeabilized cells with Pl(4,5)P2 generated ap- 
proximately twice as many exposed barbed ends as activa- 
tion using the TRAP peptide. Treatment of permeabilized 
ceils with Pi(4)P also increased the number of barbed 
ends, although Pi(4)P was somewhat less effective than 
Pl(4,5)Pn on a molar basis, and Pi(4)P concentrations of 
>lOO uM were required for maximal end exposure. This 
discrepancy may reflect the larger size of Pi(4)P particles 
compared with miceiles of Pl(4,5)P2. Phosphatylinositol 
(3,4,5)trisphosphate (Pl(3,4,5)P,) miceiles between 10 and 
33 uM were as effective as Pi(4,5)P2 in generating filament 
uncapping (Figure 4A). Phosphatidylserine (PS) vesicles 
had no effect in OG-permeabilized cells, which demon- 
strates selectivity in the uncapping reaction for the phos- 
phoinositol head group. 1,2-Dioctanolyi-sn-glycerol and 
1 oieoyl-2-acetyi-sn-glycerol reportedly promote actin nu- 
cleation activity of isolated Dictyostelium membranes 
(Shariff and Luna, 1992) but had no uncapping activity in 
permeabiiized platelets at concentrations as high as 100 
uM. Phosphatidic acid, reported to stimulate actin assem- 
bly in intact cells (Ha and Exton, 1993) however, increased 
the number of free barbed ends e-fold from 70 + 40 to 
132 f 63 (mean f SD, n = 6) at doses between 10 and 
33 PM. 
Sedimented cytoskeletons partially depleted of soluble 
compounds also increased their content of detectable free 
barbed ends in response to Pi(4,5)P2 to similar levels as 
the permeabilized cells, although higher concentrations 
of Pi(4,5)Pa were required to generate maximal filament 
uncapping (Figure 48). Pi(4,5)Pz, in the absence of cy- 
toskeletons, had no effect on the rate at which the pyrene- 
actin assembled. The increase in the actin assembly rate 
induced by adding Pi(4,5)P2 to cytoskeietons was abol- 
ished by the addition of 2 uM cytochaiasin B, demonstra- 
ting that the effect of the added phospholipid was selective 
for the barbed ends of filaments. 
Stimulation of OG-Permeabilized Platelets with 
TRAP Leads to the Production of Pl(4,5)PZ 
The major radiolabeled phospholipid detected after TRAP 
activation of permeabilized cells is Pl(4,5)P2 (Figure 5A). 
Pl(4,5)P2 synthesis increased 3-fold 60 s after the addition 
of TRAP and continued to increase thereafter (Figure 58). 
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Figure 4. Effect of Lipids or of a Phosphoinositide-Binding Peptide 
on Filament End Exposure in OG-Permeabilized Resting Platelets or 
Platelet Cytoskeletons 
(A) OG-permeabilized resting platelets were incubated with Pl(4,5)P2 
(open squares), Pl(4)P (closed squares), Pl(3,4)P2 (open triangles), 
Pl(3,4,5)P3 (closed triangles), or PS (open circles) for 1 min, and then 
actin nucleation activity was determined. 
(B) Cytoskeletons separated from resting platelet lysates remain re- 
sponsive to Pl(4,.5)PZ. Cytoskeletons were separated from the soluble 
proteins in OG-treated resting (squares) or thrombin-activated cells 
(circles) by centrifugation at 13,000 x g for 5 min in a microcentrifuge 
at room temperature. The soluble fraction was removed, and pelleted 
cytoskeletons were resuspended to original volume in 0.1 M KCI, 2 
mM MgCb, 0.5 mM ATP, 0.1 mM EGTA, 0.5 mM 2-mercaptoethanol, 
10 mM Tris (pH 7.5). and 100 ul of the suspension was added to 
each assay. Open circles, cytoskeletons from platelets activated with 
thrombin for 30 s prior to OG permeabilization; closed circles, cytoskel- 
etons from resting cells; open squares, cytoskeletons from resting 
cells treated with 150 uM PIP2 for 1 min prior to their addition to the 
pyrene-actin assembly assay; closed squares, cytoskeletons from 
resting cells treated with 75 pM PIP2 for 1 min prior to their addition to 
the pyrene-actin assembly assay; open diamonds, actin alone; closed 
diamonds, actin assembly rate in the presence of 150 pM PIP*. Each 
curve represents the mean f SD of four assays. 
(C) Concentration dependence of a 21-mer synthetic peptide corre- 
sponding to residues 150-169 of human cytoplasmic gelsolin. Inhibi- 
tion of TRAP-mediated filament end exposure at 1 min in OG- 
permeabilized platelets. 
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Figure 5. TRAP Treatment of OG-Permeabilized Resting Platelets 
Results in the Production of PIP2 
(A) Autoradiograph showing the incorporation of [p”P]ATP into chloro- 
form-methanol extractable phospholipids. 
(8) Quantification of newly synthesized PIP2 in the platelet lysates. 
Peptides That Bind to Pl(4,5)Pz Inhibit Filament 
End Exposure in Response to TRAP 
A 21 -mer gelsolin-derived ppl-binding peptide at >17 uM 
inhibited barbed filament end exposure in OG-permeabil- 
ized cells by 75% in response to TRAP, while 333 uM 
peptide concentrations completely inhibited TRAP-medi- 
ated barbed end exposure (Figure 4C). As shown in Table 
1, addition of excess exogenous Pl(4,5)P2 to the OG- 
permeabilized cells overcame the inhibitory effect of the 
ppl-binding peptide. A shorter peptide from the gelsolin 
sequence had all the inhibitory effects of the 21-mer, al- 
though higher concentrations were required to inhibit fila- 
ment end exposure in response to TRAP. A number of 
peptides of similar length and/or charge employed as 
controls, including a 25mer highly basic peptide en- 
compassing residues 151-175 of MARCKS, poly-L-lysine, 
pentalysine, and a lo-mer peptide having a random ar- 
rangement of the lo-mer gelsolin ppl-binding sequence, 
had no detectable effect on the net increase in barbed 
filament ends induced by TRAP in permeabilized platelets. 
GTP Promotes Filament Uncapping While GDP 
Inhibits Uncapping 
Table 1 shows that the addition of either GTP or GTPyS 
to OG-permeabilized platelets increased the number of 
free barbed filament ends. Of the two nucleotides, GTPyS 
was the more effective, generating free barbed filament 
end numbers comparable to those induced when Pl(4,5)P2 
was added to the permeabilized cells. GTPyS (at 10 uM) 
increased barbed end exposure by Cfold. GTP (at 33 PM) 
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Table 1. Effect of TRAP, Guanosine Nucleotides, VlPRac GTPase, Pl(4,5)P2, and PI-Mer ppl-Binding Peptide on the Exposure of Barbed 
Filament Ends in Permeabilized Platelets 
Change in Number 
of Barbed Ends 
Treatment per Platelet 
10 pM TRAP for 1 min, permeabilize 480 f 80 
Permeabilize, then 10 nM TRAP 200 * 41 
Permeabilize, then 33 pM GTP 130 f 15 
Permeabilize, then 10 pM GTPyS 290 + 20 
Permeabilize, then 100 pM GDPBS -5 f 8 
Permeabilize, then 10 CM TRAP, 100 nM GDP5S 28 f 25 
Permeabilize, then 33 pM Pl(4,5)PZ 272 + 31 
Permeabilize, then 33 pM Pl(4,5)P2 100 pM GDPgS 205 f 45 
Permeabilize, then 10 pM GTPyS, 25 pM 2l-mer ppl-binding peptide 25 f 18 
Permeabilize, then 30 pM TRAP, 20 uM ppl-binding peptide -61 + 15 
Permeabilize, then 30 CM TRAP, 20 pM ppl-binding peptide, 33 PM Pl(4,5)PZ 220 f 41 
Permeabilize, 1 pM VlPRac 271 f 79 
Permeabilize, 1 pM VlPRac and 25 pM 21-mer ppl-binding peptide -11 f 39 
We permeabilized 90 pl of 2 x 10’ platelets with 10 pl of 4% OG in PHEM buffer for 1 min at 37OC, except for the cells that were activated first 
and then permeabilized. Permeabilized cells were exposed to the various treatments for 1 min, after which they were diluted to 285 pl with 100 
mM KCI, 0.2 mM MgC12, 0.5 mM ATP, 0.1 mM EGTA, 0.5 mM 2-mercaptoethanol, and 10 mM Tris (pH 7.5). We added 15 pl of a 20 pM pyrene-labeled 
rabbit skeletal muscle G-actin to start the assay. Barbed ends were calculated as described in the Experimental Procedures. Data are expressed 
as the mean f SD for five individual experiments. The number of barbed ends per resting cell was 89 f 26. The resting end number has been 
substracted from the activated number. 
was less effective and increased the number of free 
barbed ends by only e-fold in the OG-permeabilized plate- 
lets. GDPpS did not affect the number of ends present in 
permeabilized resting cells but strongly inhibited un- 
capping of filament ends induced by TRAP. The addition 
of Pl(4,5)P2 micelles to lysates treated with GDPpS over- 
came its inhibition, while the stimulatory effect of GTP was 
abolished by the addition of the Pl-mer Pl(4,5)P2-binding 
peptide. These results indicate that the effects of GTP 
analogs are upstream from Pl(4,5)P2 in the signal trans- 
duction pathway from TRAP to filament ends. 
V12Racl Promotes Barbed Filament End Exposure 
in OG-Permeabilized Platelets 
Bacterially expressed consititutively active mutant Vl PRacl , 
but not V14RhoA, stimulated barbed filament end expo- 
sure in permeabilized platelets (Figure 6A). V12Rac1, at 
concentrations 210 nM, freed barbed filament ends to lev- 
els comparable to those obtained by adding Pl(45)P~ or 
GTP to the permeabilized cells. Concentrations of 230 
nM VlPRacl resulted in maximal activity. V14RhoA, in 
contrast, failed to free barbed filament ends even at micro- 
molar concentrations. Identical results were found using 
recombinant Racl and RhoA produced in Sf9 cells using 
baculovirus and primed with GTP and also with the consti- 
tutively active mutant forms of these proteins (data not 
shown). 
VlPRacl also stimulated the synthesis of Pl(4)P and 
Pl(4,5)P2. VlPRacl at 3 nM increased Pl(4,5)P2 synthesis 
by 2.4-fold and barbed end exposure by 3-foldjn the OG- 
permeabilized cells, and concentrations of Vl2Racl >30 
nM maximally stimulated both Pl(4,5)P2 synthesis and fil- 
ament end exposure (Figure 6B). To establish whether 
the effect of V12Racl on filament uncapping was direct 
or mediated by upstream signaling to phosphoinositide- 
kinases, experiments were performed using the ppl-bind- 
ing peptide. The 21 -mer ppl-binding peptide at 25 uM com- 
pletely abolished Rat-dependent filament uncapping 
(Table l), indicating that this GTPase functions upstream 
of Pl(4,5)P2 production. 
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Figure 6. Active Rat but Not Rho Uncaps Barbed Ends and Stimu- 
lates PIP, Labeling in Permeabilized Platelets 
(A) Comparison of the effect of recombinant mutant GTPases VlPRac 
and V14Rho on filament end exposure in OG-permeabilired platelets. 
(B) Mutant recombinant rat lysates stimulates the production of PIP, 
and filament uncapping in OG-permeabilized resting platelets: com- 
parison of dose responses. 
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Discussion 
Permeabiiized Platelets That Uncap Actin Filament 
Barbed Ends in Response to Stimulation 
Permeabiiization has been a useful approach to advancing 
understanding of signal transduction mechanisms in ceils 
including platelets (Hasiam and Davidson, 1984; King et 
al., 1991; Kucera and Rittenhouse, 1990). When the sig- 
naling involves membrane lipids, as hypothesized for 
platelet actin remodeling, the challenge is to breach the 
membrane barrier sufficiently to add intermediates, yet to 
leave enough membrane intact to participate in messen- 
ger activity. We found that this goal could be accomplished 
with a precise ratio of the detergent OG to platelets that 
opened 29-100 nm holes in the platelet membrane yet 
left membrane domains in which thrombin receptors could 
couple downstream partners, activate phosphoinositide 
kinases, and synthesize polyphosphoinositides using en- 
dogenous substrates spared by the detergent treatment. 
Platelets permeabiiized with 0.4% OG responded to TRAP 
by uncapping actin filament barbed ends and by concomi- 
tantly synthesizing Pi(4,5)Pn when supplied with ATP. 
Higher OG concentrations or another detergent, Triton 
X-100, rendered the platelets unresponsive. 
The extent of barbed end uncapping was greatest in 
intact platelets stimulated by thrombin receptor ligation, 
which uncapped twice the number of filaments uncapped 
in OG-permeabilized and subsequently stimulated ceils. 
One explanation for this difference could be that signaling 
intermediates were lost during permeabilization. How- 
ever, one important difference between the two types of 
preparations is that intact ceils are capable of increasing 
intracellular calcium, whereas the permeabiiized ceils, be- 
ing suspended in EGTAcontaining buffer solutions, are 
not. Since the calcium transient of intact ceils elicits actin 
filament severing and increases the number of capped 
barbed ends available for subsequent uncapping (Hart- 
wig, 1992), the absence of a calcium rise could therefore 
account for the fewer ends uncapped in permeabiiized 
and subsequently stimulated ceils. in support of this expia- 
nation is the fact that the number of ends uncapped in 
these ceils approximates the number uncapped in piate- 
lets activated under conditions in which intracellular cal- 
cium remains in the nanomolar range (Hat-twig, 1992) or 
in cells lacking gelsolin (Witke et al., 1995). 
Evidence That Phosphoinositides Are the Terminal 
Step of Stimulated Actin Assembly in Platelets 
First, the D3 and D4 poiyphosphoinositides uncap barbed 
filament ends in OG-permeabiiized platelets. Data pre- 
sented here represent evidence that a phosphoinositide 
with a phosphate in the 3 as well as the 4 and 5 positions 
on the inositoi ring can uncap actin filament barbed ends. 
Thrombin (and TRAP) can cause normal actin assembly 
in platelets treated with inhibitors of phosphoinositide 
3-kinase with undetectable D3 phosphoinositide biosyn- 
thesis (Kovacsovics et al., 1995) although some types of 
actin remodeling in platelets and other cells may still result 
from actin filament uncapping by this class of phospholip- 
ids (S. Kung, A. T., T. J. Kovacsovics, and J. H. H., unpub- 
lished data). The results also are interesting because pre- 
vious studies of phosphoinositide effects on gelsolin-actin 
interactions have shown that these phosphoiipids are very 
effective in preventing geisolin and other capping proteins 
from binding to actin filaments in vitro, but are inefficient in 
removing geisoiin and capping protein from actin filament 
barbed ends except when gelsolin-capped filaments were 
treated shortly after their formation (Janmey and Stossei, 
1989). The ability of phosphoinositides to uncap actin fila- 
ment barbed ends in permeabilized platelets may be attrib- 
utable to a different configuration of gelsolin-actin interac- 
tion in the platelet compared with in vitro, to capping 
proteins other than gelsolin, or to as yet unknown factors. 
The ability to uncap barbed actin filament ends is specific 
for the three phosphoinositides examined, as several 
other lipids assayed did not have this effect. On the other 
hand, phosphatidic acid was about 250/o-50% as effective 
as the poiyphosphoinositides in uncapping actin filament 
barbed ends of OG-permeabiiized platelets. Phosphatidic 
acid stimulates actin assembly in intact cultured fibro- 
blasts (Ha and Exton, 1993), but has no inhibitory effect 
on the interaction between barbed end capping proteins 
and actin. Since phosphatidic acid reportedly activates 
phosphoinositide-synthesizing enzymes (Moritz et al., 
1992) its effects on actin assembly could be indirect 
through the induction of phosphoinositides. 
Second, TRAP induces both barbed end actin filament 
uncapping and phosphoinositide biosynthesis in intact 
and OG-permeabiiized platelets. The time course of phos- 
phoinositide synthesis is rapid and could therefore ac- 
count for local phospholipid accumulation capable of 
uncapping actin filament barbed ends. The total phospho- 
inositide concentrations in resting platelets, if in the form 
of clusters, are high enough to uncap actin filaments in 
permeabiiized platelets. Therefore, not all of this lipid is 
accessible to capped barbed ends, and the newly gener- 
ated phosphoinositides are required for uncapping. 
Third, peptides derived from geisoiin that specifically 
bind Pl(4,5)P2 with high affinity (Janmey et al., 1992) but 
not several control peptides that lack such binding, are 
potent inhibitors of stimulus-induced actin filament barbed 
end uncapping in OG-permeabilized platelets. 
The GTPase Rat Leads to Phosphoinositide 
Synthesis-Mediated Barbed End Uncapping 
of Actin Filaments 
Recent work has elucidated how different stimuli can pro- 
mote particular types of actin assembly within ceils (Hail, 
1993,1994). One key ingredient of this specification is the 
speciesof GTPase recruited by the stimulus. For example, 
acting through the GTPase Rho, lysophosphatidic acid in 
serum builds adhesion plaques and actin filament-rich 
stress fiber bundles in certain cultured ceils (Jalink et al., 
1994; Ridley and Hail, 1992). Working through the GTPase 
Rat, growth factors direct actin remodeling in pleat-like 
protrusions, the ruffles, of such ceils (Ridley et al., 1992). 
Yet another GTPase, CDC42, appears to program the ac- 
tin-based assembly that results in protrusion of hair-like 
filopodia and is an upstream regulator of Rat (Nobes and 
Hall, 1995). Given these important clues and the additional 
findings that Rho reportedly stimulates Pl(4)P 5-kinase in 
vitro (Chong et al., 1994) and that nonhydrolyzable GTP 
analogs stimulate cellular phosphoinositide generation 
(Stephens et al., 1993) we were logically directed to exam- 
ine whether addition or perturbation of these GTPases 
would uncap barbed ends of actin filaments in OG- 
permeabilized platelets. 
Our findings indicate that particular GTPases stimulate 
phosphoinositide kinass activities that uncap actin fila- 
ments in specific locations (Figure 7). First, GTP and 
GTP-rS alone promoted barbed filament end uncapping 
in permeabilized platelets; GDPQS, predicted to inhibit the 
transducing activity of GTPases, not only failed to induce 
uncapping but inhibited TRAP-activated uncapping. Simi- 
lar stimulatory or inhibitory effects on actin assembly by 
GTP and GDPQS, respectively, have been observed in 
permeabilized neutrophils (Redmond et al., 1994). We 
showed that Pl(4,5)Pn micelles, however, produced barbed 
end actin filament uncapping in OG-permeabilized plate- 
lets exposed to GDPBS. These results would be expected 
if GTP hydrolysis precedes phosphoinositide synthesis in 
the pathway to actin filament uncapping. Second, we 
found that constitutively active mutant Vl2Rac, but not 
active V14Rho, elicited barbed end uncapping in parallel 
with activation of Pl(4,5)P2 biosynthesis in OG-permeabil- 
ized platelets. Third, induction of actin filament barbed 
end uncapping in OG-permeabilized platelets by GTP and 
GTPyS, and by constitutively active Rat were inhibited by 
the same concentrations of Pl(4,5)P2-binding peptide that 
prevented TRAP-induced barbed end uncapping. 
In summary, OG-permeabilized platelets retain stimu- 
lus-responsive signaling pathways that lead to an actin 
filament barbed end uncapping reaction. Evidence pre- 
sented here points to phosphoinositide-mediated un- 
capping of actin filament ends as the last step in this path- 
way. GTPase activity, driven by Rat, works upstream to 
stimulate phosphoinositide biosynthesis. This regulatory 
design could program the precise spatial generation of 
Thrombin 
the phosphoinositides near actin filament barbed ends. In 
platelets, particular GTPases could program the different 
types of actin assembly leading to lamellae or filopodia. 
This system should lend itself to further elucidation of 
steps involved in what will undoubtedly be a complex and 
fascinating control panel regulating the platelet shape 
change. The lessons learned should also be applicable 
to other kinds of cells. 
Experimental Procedures 
Preparation of Resting Platelets 
Human blood from healthy volunteers, drawn into 1110 vol of Aster- 
Jandl anticoagulant, was centrifuged at 110 x g for 10 min. The plate- 
let-rich plasma was gel filtered at room temperature through a Sepha- 
rose 28 column, equilibrated, and eluted with a solution containing 
146 mM NaCI. 10 mM HEPES, 10 mM glucose, 0.5 mM NazHPO,. 5 
mM KCI, 2 mM MgCL, and 0.3% bovine serum albumin (pH 7.4) (plate- 
let buffer). Cells were incubated for 30 min at 37OC to insure a resting 
state. 
Permeablllzatlon of Platelets 
Resting platelets, -2 x lOVml, were lysed using 0.1 vol of OG (final 
concentrations of 0.1%-0.7%), 60 mM PIPES, 25 mM HEPES, 10 mM 
EGTA, 2 mM MgCI,, 20 uM phallacidin, and 42 nM leupeptin. 10 mM 
benzamidine, and 0.123 mM aprotinin to inhibit proteases (Hartwig, 
1992). To determine the minimal (rest) and maximal (active) number 
of filament ends exposed in cells, resting platelets were permeabilized 
by the addition of 0.1 vol of above buffer containing 0.75% Triton 
instead of CG before or 60 s after addition of 10 uM TRAP. In some 
experiments, the cytoskeletal fraction was separated from the total 
lysate by centrifugation at 12,300 x g for 5 min in a Sorvall Microspin 
centrifuge. The cytoskeletal pellet that resulted from this centrifugation 
was resuspended at its original volume in the above buffer lacking 
added detergent. 
Actlvatlon of Platelets 
Platelets in suspension, detergent-permeabilized platelets from rest- 
ing cells, or the cytoskeletal portion of permeabilized platelets were 
activated by the addition of thrombin receptor-activating peptides, 
either the llresidue (TRAP) or the Sresidue (TBAF) forms (Bachem, 
King of Prussia, PA), for 60 s. When intact cells were used, activation 
was terminated by permeabilizing the cells as detailed below. 
Fluorescence Measurement of Filament End Status 
The effect of cell lysates on the rate and extent of pyrene-labeled actin 
was determined as described previously (Hartwig, 1992). Resting or 
TRAP-activated cells (90 ul) were permeabilized with 10 ul of 4% OG, 
or 100 ul of permeabilized resting cells were exposed to TRAP or 
Figure 7. Summary Scheme of the Pathway 
from the Thrombin Receptor to Actin Filament 
Ends in Platelets 
The thrombin receptor couples to phosphoino- 
sitide kinases through the small G protein Rat. 
The ppl-binding peptides block the exposure 
of newly synthesized phosphoinositides. 
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TRAF for 60 s and then added to 165 ul of 100 mM KCI, 2 mM MgCI,, 
0.5 mM ATP, 0.1 mM EGTA, 0.5 mM dithiothreitol, and 10 mM Tris 
(pH 7.0). The polymerization rate assay started by the addition of mono- 
meric pyrene-labeled rabbit skeletal muscle actin to a final concentra- 
tion of 1 pM. The relative contribution of exposed barbed or pointed 
filament ends in detergent-permeabilized cells was determined by add- 
ing 2 pM cytochalasin B to the pyrene-actin assembly assay. Pyrene- 
actin assembly onto actin filament ends is completely inhibited at the 
barbed end by 2 pM cytochalasin B in this assay (Hartwig, 1992). The 
barbed end assembly rate is calculated by subtracting the assembly 
rate in the presence of cytochalasin B from the assembly rate in the 
absence of cytochalasin B. Activity not inhibited by cytochalasin B 
in this assay derives from the pointed end of filaments. Barbed end 
numbers were calculated from the number of actin monomers adding 
to the barbed end per second (derived from the change in fluorescence 
per second) divided by the actin monomer addition rate at the barbed 
end (10 subunits/s) at the added 1 uM actin concentrations and the 
number of cells per assay (1.6 x 10’ cells). 
Measurement of Actin Filament Assembly 
A rhodamine-phalloidin-based flow cytometry assay was used to 
quantitate the actin filament content of resting and activated platelets 
(Howard and Oresajo, 1965). The fluorescence of bound rhodamine- 
phalloidin is proportional to the total amount of F-actin. Platelets under 
resting or activating conditions were fixed by the addition of an equal 
volume of 4% paraformaldehyde in platelet buffer without BSA for 
30 min at 37OC. Fixed platelets were made permeable with a final 
concentration of 0.1% Triton X-100 and labeled with 10 pM rhoda- 
mine-phalloidin for 30 min at room temperature. The samples were 
immediately read in a Be&ton-Dickinson FACScan flow cytometer. 
The samples were gated for platelets based on their forward- and 
side-scatter profile. The results are expressed as percent F-actin. 
Phospholipids 
Phosphatidylserine (dipalmitoyl-L-a-phosphatidylserine) (PS), Pl(4)P, 
Pl(4,5)P2, phosphatidic acid (PA), and 1,2dioctanolyl-sn-glycerol 
(diC8) were obtained from Sigma (St. Louis, MO). Pl(3.4)P2 was pur- 
chased from Matreya, Incorporated (Pleasant Gap, PA). Pl(3,4,5)P3 
was a gift from Drs. D.-M. Gou and C.-S. Chen (College of Pharmacy, 
University of Rhode Island, Kingston, RI) (Gou and Chen, 1994). PA, 
PS, Pl(4)P, Pl(4,5)PZ, Pl(3,4)P2, and Pi(3,4,5)PJ were dissolved by son- 
ication in water as described by Janmey and Stossel(l969). diC8 was 
prepared and added to platelet lysates as described by Shariff and 
Luna (1992). 
PoiyphosphoinositldeBinding Peptides 
Two peptides based on a ppi-binding site in gelsolin (Janmey et al., 
1992) were synthesized and HPLC purified: a 1 O-mer peptide encoding 
gelsolin residues 160-i 69 (QRLFQVKGRR) (a gift of R. Vegners, Lat- 
vian Institute of Organic Synthesis, Riga, Latvia) and a Pl-mer peptide 
containing residues 150-l 69 of cytoplasmic gelsolin to which a cyste- 
ine residue was added at the amino terminus (CKHVVPNEVWQRLF- 
QVKGRR). Control peptides include a 25-mer peptide based on the 
sequence of MARCKS, residues 151-175 (acetyl-KKKKKRFSFKKSF- 
KLSGFSFKKNKK), that was agift of A. Aderem, Rockefeller University 
(New York, New York) and a random peptide having the same residues 
as the gelsolin IO-mer (FRVKLKQGQR). All peptides were dissolved 
in water. 
Small GTP-Binding Proteins 
Recombinant bacterial Vi2Racl and V14RhoA were prepared by Dr. 
T. Azuma using cDNAs provided by Dr. A. Hall (University College 
London, London, England) by the method of Ridley et al. (Ridley and 
Hall, 1992; Ridley et al., 1992). Recombinant processed GTPase pro- 
teins were purified from Sf9 insect cell using a baculovirus expression 
system (Heyworth et al., 1993) as described by Chong et al. (1994). 
All GTPase proteins were charged with GTP using a IO-fold excess 
of GTP to GTPase protein in 20 mM Tris, 1 mM EDTA, 100 mM NaCI, 
and 1 mM DlT (pH 7.5) for 15 min at 30°C. The GTP-loading reaction 
was stopped by adding 5 mM MgCI,. 
Assay of Phospholipld Mass and Production 
Gel-filtered platelets (lOO/ml) were incubated with 2 mCi/ml [“Plortho- 
phosphoric acid for 1 hr at 37“C. Unbound =P was separated from 
the cells by gel filtration in the presence of 1 uM postaglandin El. 
Resting and activated lipids were analyzed as described in Kovac- 
sovics et al. (1995). 
Resting platelets at concentrations from 2 x lOa- x IWml were 
permeabilized for 1 min at 37OC using a final QG concentration of 
0.4%. Permeabilized cells were then treated with the TRAP peptide 
or recombinant VI PRacl protein in the presence of 50-l 06 f&i/ml of 
[y-=P]ATP, added along with the activating agent. At different times, 
the reaction was stopped by removing 1 ml of the lysate solution. 
Lysates were processed by two procedures for TLC analysis. 
Procedure 7 
Solution (1 ml) was added to 3.6 ml of a 20:40:1:2 solution of chloro- 
form:methanol:12 N HC1:O.i M EDTA and vigorously mixed using a 
vortex for 20 s (Auger et al., 1969a, 1989b). To this solution, 1.25 ml 
each of ice-cold chloroform and distilled water were added. The solu- 
tion was mixed using a vortex, and its phases were separated by 
centrifugation at 1300 x g for 10 min at 4OC. The upper phase was 
discarded, and the lower phase was washed a second time with 2.5 
ml of 3:48:7 solution of chloroform:methanol:0.6 N HCI. The phases 
were again separated by centrifugation, the upper phase was dis- 
carded, and the organic phase was dried under nitrogen gas, washed 
with 1 ml of chloroform, and dried. Dried material was resuspended 
in 200 pl of chloroform containing 0.5 mM butylated hydroxytoluene. 
Each sample (40 pl) was applied to one lane of a 20 x 20 cm Silica gel 
15OA TLC plate (Whatman International Limited, Maidstone, England) 
that had been pregrooved (19 channels). The TLC plate was coated 
with 1% potassium oxalate and dried at 1 10°C for a minimum of 30 
min prior to sample application. Phosphoiipids were separated by chro- 
matography in 60:47:11.3:2 of chloroform:methanol:water:8.56 M 
NHdOH. The location of PIP, PiP2, and PIPS was determined using a 
known standard solution. Plates were stained by placing them in a 
saturated iodine tank. =P incorporated into phospholipids was re- 
vealed by autoradiography. 
Procedure 2 
Lysate (1 ml) was added to 300 pl of 3 M HCI followed by 2 ml of 50: 
50 chloroform:methanol (Whitman et al., 1987). The organic and water 
phases were separated by centrifugation at 12,300 x g for 30 s, the 
water phase was discarded, and the chloroform:methanol phases were 
dried under nitrogen. Samples were resuspended in chloroform con- 
taining 0.5 mM butylated hydroxyltoluene, and phospholipids were 
separated by TLC using a solvent of 65:35 of I-propanol:2 M acetic 
acid. Plates were stained by placing them in a saturated iodine tank. 
=P incorporated into phospholipids was revealed by autoradiography. 
The density of radiolabeled phospholipid bands was quantified by dig- 
itizing the image followed by pixel counts (Molecular Dynamics). 
Electron Microscopy 
Resting platelets suspended in platelet buffer were treated with final 
concentrations of the detergent OG from 0.2%-0.5% for 2 min and 
attached to the surface of polylysine-coated glass coverslips by centrif- 
ugation at 280 x g for 5 min. The cells were fixed with 1% glutaralde 
hyde in PHEM buffer for 10 min, washed extensively into distilled 
water, rapidly frozen, freeze dried at -90°C, and coated with 1.4 nm 
of platinum with rotation and 2.5 nm of carbon without rotation 
(Cressington CFE-50 apparatus, Watford, England). Replicas were 
separated from the coverslips in 25% hydrofluoric acid, cleaned, and 
picked up on carbon-formvar-coated copper grids. Specimens were 
photographed at 100 kV in a JEOL-1200 EX electron microscope. 
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